Please provide your email address to receive an email when new articles are posted on . Fixed, firm, focal unyielding resistance was the most common finding when probing patients with obstructive ...
Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...
Please provide your email address to receive an email when new articles are posted on . Subjective grading was significantly different between Visante OCT and Keratograph 5M for the lower eyelid but ...
Dry eye disease is a condition that afflicts millions of people worldwide, causing constant discomfort and affecting their quality of life. One of the key culprits behind this condition is meibomian ...
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage company developing innovative therapies for Meibomian gland dysfunction (MGD) and related eye ...
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular ...
Dry eye disease (DED) affects nearly 16 million Americans. This multifactorial condition, characterized by rapid tear evaporation or decreased tear production, can cause symptoms from eye irritation ...
Meibomitis is a chronic inflammation of the tiny oil glands that line your upper and lower eyelids. The meibomian glands release meibum, the special oil that helps lubricate your eyes and keep your ...
NEW HAVEN, Conn. (WTNH) – On today’s edition of “CT BUZZ,” Reporter Jillian Andrews met with Dr. Donald Higgins, Optometrist and Medical Director of the Dry Eye Treatment Center of Connecticut, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback